Suppr超能文献

德国神经外科学会血管神经外科学分会:关于国际蛛网膜下腔出血试验(ISAT)的立场声明。

German Society of Neurosurgery Section on Vascular Neurosurgery: Position Statement on the International Subarachnoid Hemorrhage Trial (ISAT).

作者信息

Raabe A, Schmiedek P, Seifert V, Stolke D

机构信息

Klinik und Poliklinik für Neurochirurgie, Johann Wolfgang Goethe-Universität Frankfurt am Main, Germany.

出版信息

Zentralbl Neurochir. 2003;64(3):99-103. doi: 10.1055/s-2003-41879.

Abstract

The outcome after a specific treatment (clipping or coiling) of ruptured intracranial aneurysms is determined by both the periprocedural complication rate and the success of preventing re-bleeding from the treated aneurysm. The latter is associated with a cumulative risk over many years, particularly in incompletely treated aneurysms. Incomplete occlusion of the aneurysm is not infrequently seen after endovascular coiling, even in cases with a perfect anatomical configuration. Therefore, we believe that the 1-year outcome as reported in the ISAT is not an appropriate endpoint for the comparison of both methods. There has also been a tendency to apply the 1-year ISAT data to all patients harbouring intracranial aneurysms. It is inappropriate and dangerous to be less critical when selecting the endovascular approach as the method of choice for treating an aneurysm. This will ultimately result in a higher complication rate of coiling. Another striking finding is the poor surgical outcome in the ISAT. This good-grade patient population (94 % were WFNS grade 1-3 and 89 % were WFNS grade 1-2) had an almost 10 % higher rate of poor outcome compared to other good-grade patients in large prospective surgical studies or the same outcome as trials that included up to 20 % poor-grade patients.[nl]Neurosurgeons should acknowledge that endovascular coiling is a safe method associated with less complications than clipping in experienced hands (Fig. ). Endovascular radiologists should acknowledge that the success of complete obliteration is higher after surgery, that incompletely occluded aneurysms have a higher rate of re-rupture and that the definitive long-term re-rupture rate still remains unknown. Therefore, we await with interest the angiographic and clinical follow-up data that will provide evidence about the final patient outcome.

摘要

颅内破裂动脉瘤进行特定治疗(夹闭或血管内栓塞)后的结果取决于围手术期并发症发生率以及预防治疗后动脉瘤再出血的成功率。后者与多年累积风险相关,尤其是在治疗不完全的动脉瘤中。即使在解剖结构完美的情况下,血管内栓塞术后动脉瘤不完全闭塞的情况也并不少见。因此,我们认为国际蛛网膜下腔动脉瘤试验(ISAT)所报告的1年结果并非比较这两种治疗方法的合适终点。此外,还存在将ISAT的1年数据应用于所有颅内动脉瘤患者的趋势。在选择血管内治疗作为动脉瘤治疗的首选方法时降低标准是不合适且危险的,这最终会导致血管内栓塞的并发症发生率更高。另一个显著发现是ISAT中手术结果不佳。在这项优良分级的患者群体中(94%为世界神经外科联合会(WFNS)1 - 3级,89%为WFNS 1 - 2级),与大型前瞻性手术研究中的其他优良分级患者相比,不良结果发生率高出近10%,或者与纳入高达20%不良分级患者的试验结果相同。

神经外科医生应认识到,在经验丰富的医生手中,血管内栓塞是一种安全的方法,其并发症比夹闭少(图)。血管内放射科医生应认识到,手术后完全闭塞的成功率更高,不完全闭塞的动脉瘤再破裂率更高,且最终长期再破裂率仍然未知。因此,我们饶有兴趣地等待血管造影和临床随访数据,这些数据将为患者的最终结局提供证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验